AGP Picks
View all

Yemen Health Report
Provided by AGP

Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on May 14, 2026

AUA Guidelines Strengthen Recommendation for Aquablation® Therapy
May 14, 2026

AUA Guidelines Strengthen Recommendation for Aquablation® Therapy

Indeterminate GlobeNewswire
Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuction
May 14, 2026

Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuction

Indeterminate GlobeNewswire
IN8bio Presents New Translational Data Demonstrating DeltEx DRI Reshapes the Immune Landscape in Glioblastoma
May 14, 2026

IN8bio Presents New Translational Data Demonstrating DeltEx DRI Reshapes the Immune Landscape in Glioblastoma

Indeterminate GlobeNewswire
Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights
May 14, 2026

Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights

Indeterminate GlobeNewswire
Pharmazz, Inc. Appoints Ajay Bansal as Chief Financial Officer
May 14, 2026

Pharmazz, Inc. Appoints Ajay Bansal as Chief Financial Officer

Indeterminate GlobeNewswire
Brain Cancer Canada Invests $75,000 in Groundbreaking Phase 2 Clinical Trial at Sunnybrook Health Sciences Centre to Target Hard-to-Treat Glioblastoma in Older Patients
May 14, 2026

Brain Cancer Canada Invests $75,000 in Groundbreaking Phase 2 Clinical Trial at Sunnybrook Health Sciences Centre to Target Hard-to-Treat Glioblastoma in Older Patients

Indeterminate GlobeNewswire
CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy
May 14, 2026

CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy

Indeterminate GlobeNewswire
Synergy CHC Corp. Reports First Quarter 2026 Financial Results
May 14, 2026

Synergy CHC Corp. Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M
May 14, 2026

Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M

Indeterminate GlobeNewswire
Legal Steroids for Beginners 2026: (Muscle Growth And Fat Loss) Crazy Bulk Launched Safest Legal Steroid Alternatives Without Side Effects In USA.
May 14, 2026

Legal Steroids for Beginners 2026: (Muscle Growth And Fat Loss) Crazy Bulk Launched Safest Legal Steroid Alternatives Without Side Effects In USA.

Indeterminate GlobeNewswire
Agomab to Participate in Upcoming Conferences
May 14, 2026

Agomab to Participate in Upcoming Conferences

Indeterminate GlobeNewswire
Nuvectis Pharma, Inc. To Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
May 14, 2026

Nuvectis Pharma, Inc. To Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

Indeterminate GlobeNewswire
BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer
May 14, 2026

BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer

Indeterminate GlobeNewswire
Cormedix Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026

Cormedix Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
HCW Biologics Discovers that HCW11-040 Prevents Bronchopulmonary Dysplasia (BPD) During IND-Enabling Studies
May 14, 2026

HCW Biologics Discovers that HCW11-040 Prevents Bronchopulmonary Dysplasia (BPD) During IND-Enabling Studies

Indeterminate GlobeNewswire
MiNK Therapeutics and First Lviv Territorial Medical Union Initiate Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness
May 14, 2026

MiNK Therapeutics and First Lviv Territorial Medical Union Initiate Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness

Indeterminate GlobeNewswire
Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update
May 14, 2026

Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update

Indeterminate GlobeNewswire
Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026

Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Indivior to Participate in Upcoming Investor Conferences
May 14, 2026

Indivior to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Tonix Pharmaceuticals to Present Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at ISPOR 2026
May 14, 2026

Tonix Pharmaceuticals to Present Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at ISPOR 2026

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Yemen Health Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.